Home › Idiopathic Pulmonary Fibrosis › North Carolina
Idiopathic Pulmonary Fibrosis clinical trials in North Carolina
10 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in North Carolina.
Cities in North Carolina
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Piedmont HealthCare, PA, Statesville
- Southeastern Research Center, Winston-Salem
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Greensboro
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Clinical Research of Gastonia (CRG), Gastonia
- Southeastern Research Center, Winston-Salem
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- UNC Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- UNC Chapel Hill, Chapel Hill
- Duke University, Durham
- Pulmonix LLC, Greensboro
- and 1 more
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Durham, NC, Durham
- WISPer site in Greensboro, NC, Greensboro
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 28, 2026 · NCT06325696Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Southeastern Research Center, Winston-Salem
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.